Burkholderia pseudomallei Capsular Polysaccharide Recognition by a Monoclonal Antibody Reveals Key Details toward a Biodefense Vaccine and Diagnostics against Melioidosis

详细信息    查看全文

• 作者：Roberta Marchetti ; Michael J. Dillon ; Mary N. Burtnick ; Mark A. Hubbard ; Marielle Tamigney Kenfack ; Yves Bl茅riot ; Charles Gauthier ; Paul J. Brett ; David P. AuCoin ; Rosa Lanzetta ; Alba Silipo ; Antonio Molinaro
• 刊名：ACS Chemical Biology
• 出版年：2015
• 出版时间：October 16, 2015
• 年：2015
• 卷：10
• 期：10
• 页码：2295-2302
• 全文大小：433K
• ISSN：1554-8937

文摘

Burkholderia pseudomallei is the bacterium responsible for melioidosis, an infectious disease with high mortality rates. Since melioidosis is a significant public health concern in endemic regions and the organism is currently classified as a potential biothreat agent, the development of effective vaccines and rapid diagnostics is a priority. The capsular polysaccharide (CPS) expressed by B. pseudomallei is a highly conserved virulence factor and a protective antigen. Because of this, CPS is considered an attractive antigen for use in the development of both vaccines and diagnostics. In the present study, we describe the interactions of CPS with the murine monoclonal antibody (mAb) 4C4 using a multidisciplinary approach including organic synthesis, molecular biology techniques, surface plasmon resonance, and nuclear magnetic spectroscopy. Using these methods, we determined the mode of binding between mAb 4C4 and native CPS or ad hoc synthesized capsular polysaccharide fragments. Interestingly, we demonstrated that the O-acetyl moiety of CPS is essential for the interaction of the CPS epitope with mAb 4C4. Collectively, our results provide important insights into the structural features of B. pseudomallei CPS that enable antibody recognition that may help the rational design of CPS-based vaccine candidates. In addition, our findings confirm that the mAb 4C4 is suitable for use in an antibody-based detection assay for diagnosis of B. pseudomallei infections.